Fresh hope for relapsed T-cell acute lymphoblastic leukemia
BioTechniques News Tristan Free A global collaboration between Tampere University (Finland), the Massachusetts General Research Institute and the Harvard Stem Cell Institute (both MA, USA) has found a new drug combination that is effective against T-cell acute lymphoblastic leukemia – otherwise known as T-ALL. T-ALL is a form of ALL (the most common childhood cancer) […]